⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LQDA News
Liquidia Corporation Common Stock
FDA Grants Fast Track Designation to YUTREPIA® for the Treatment of Raynaud's Phenomenon Associated with Systemic Sclerosis
globenewswire.com
LQDA
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress
globenewswire.com
LQDA
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference
globenewswire.com
LQDA
Form 8-K
sec.gov
LQDA
Liquidia Corporation Reports Second Quarter 2026 Financial Results
globenewswire.com
LQDA
Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026
globenewswire.com
LQDA
Form 8-K
sec.gov
LQDA
Liquidia Announces Poster Presentations at the PHA 2026 International PH Conference and Scientific Sessions
globenewswire.com
LQDA
Form 8-K
sec.gov
LQDA
Corsair Pharma Announces Three Presentations of Phase 1 Clinical Data for TRX-248 Transdermal System at the 2026 Pulmonary Hypertension Association Conference
businesswire.com
UTHR
LQDA